Nektar Therapeutics (NKTR) EBITDA Margin Growth (5y) (2015 - 2026)
Nektar Therapeutics (NKTR) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Nektar Therapeutics | 1.49 Bn | 919.46 Mn | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,302.00 |
| Dec 31, 2025 | 34,505.00 |
| Sep 30, 2025 | 7,449.00 |
| Jun 30, 2025 | -16,512.00 |
| Mar 31, 2025 | -16,153.00 |
| Dec 31, 2024 | 37,296.00 |
| Sep 30, 2024 | 19,557.00 |
| Jun 30, 2024 | 26,406.00 |
| Mar 31, 2024 | 26,392.00 |
| Dec 31, 2023 | 11,153.00 |
| Sep 30, 2023 | 16,947.00 |
| Jun 30, 2023 | -33,635.00 |
| Mar 31, 2023 | -39,568.00 |
| Dec 31, 2022 | -21,307.00 |
| Jun 30, 2022 | -56,161.00 |
| Mar 31, 2022 | -24,944.00 |
| Dec 31, 2021 | -36,564.00 |
| Sep 30, 2021 | -23,198.00 |
| Jun 30, 2021 | -9,115.00 |
| Mar 31, 2021 | -44,650.00 |